Tin tức & Cập nhật

Ngày kĩ thuật IVF thế giới - 25/07/2024

Vô sinh, hiếm muộn đang dần trở thành mối lo ngại của các cặp vợ chồng hiện nay.

Theo thống kê của Bộ Y tế, ước tính có khoảng 7,7% dân số Việt Nam đang đối mặt với vấn đề này. Tình trạng này không những ảnh hưởng đến hạnh phúc của các cặp vợ chồng mà còn tác động đến xã hội do tỉ lệ sinh giảm.

Weight trajectories across reproductive years up risk of adverse pregnancy outcomes

Weight gains prior to and between pregnancies appear to increase the risk of adverse pregnancy outcomes (APOs), reports a study. A longer period of weight gain shows the most robust association with an increased risk of APOs.

Product Highlight - GARDASIL®9

Vắc-xin tái tổ hợp, hấp phụ phòng 9 týp vi-rút HPV ở người

Can new mums shed their baby weight through breastfeeding?

Breastfeeding mothers in Singapore appear to have an edge over those who feed their newborns formula in terms of shedding some baby weight, according to a study.

Postexertional malaise, fatigue common PASC symptoms in pregnant women

Nearly 10 percent of pregnant women experience postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), with the most common symptoms including postexertional malaise, fatigue, and gastrointestinal symptoms, according to a study.

Placental abruption in ART pregnancies poses risk of preterm delivery

The occurrence of placental abruption in pregnant women who conceived via assisted reproductive technology (ART) contributes to an increased risk of preterm delivery, as reported in a cross-sectional study.

Follow-up testing in cervical cancer screening remains low in SG

A recent study has found an “unacceptably low” compliance of follow-up following abnormal human papillomavirus (HPV) tests among women in Singapore.

Vaginal estrogen therapy safe for some breast cancer patients, but may pose risk for others

Vaginal estrogen therapy may be safely used to treat genitourinary symptoms in early-stage breast cancer patients with HR-negative tumours and in those concurrently treated with tamoxifen, according to the results of a target trial emulation. However, its use may be detrimental to disease-free survival (DFS) outcomes in patients receiving aromatase inhibitors.